Engineered HCMV-infected APCs enable the identification of new immunodominant HLA-restricted epitopes of anti-HCMV T-cell immunity.
Santamorena MM, Tischer-Zimmermann S, Bonifacius A, Mireisz CN, Costa B, Khan F, Kulkarni U, Lauruschkat CD, Sampaio KL, Stripecke R, Blasczyk R, Maecker-Kolhoff B, Kraus S, Schlosser A, Cicin-Sain L, Kalinke U, Eiz-Vesper B.
Santamorena MM, et al. Among authors: sampaio kl.
HLA. 2024 Jun;103(6):e15541. doi: 10.1111/tan.15541.
HLA. 2024.
PMID: 38923358